• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Last Chance to buy the New Mad Hedge Biotech and Healthcare Letter at the Founders Price, or The Newsletter That May Save Your Life!

Diary, Newsletter, Research

This weekend, we are closing down our discount offer page to buy the New Mad Hedge Biotech and Healthcare Letter at the Founders Price for only $997.

There are two stock sectors that will most likely deliver 80% of the total market return over the coming decade. You already know one of them. The other is:

Biotechnology and Healthcare

An exciting combination of new technologies is coming together, much like the creation of the PC, Windows, and the Internet launched all at the same time in the early 1990s. The result of that revolution was a 10-fold to 1,000-fold increase in many stock prices.

They are about to replay the same movie again! Except this time, biotech and healthcare shares will be the big beneficiaries.

Long held back as a political punching bag, Biotechnology and Healthcare shares are about to break free of their past restraints. The ten baggers will be a dime a dozen. The drivers are very simple:

*Our understanding of the human genome is growing at an exponential rate

*The development of new supercomputers and big data is answering research questions once considered impossible

*Most major human diseases will be cured over the next decade

*US healthcare, the last 19th-century industry, is about to undergo a major restructuring, delivering immense profits

*Diabetes, arthritis, and dementia will all be treated with simple daily pills

*Artificial intelligence is vastly accelerating all of the above trends

With Your Subscription You Will Get:

1) A twice-weekly research newsletter highlighting the most important developments in biotech and healthcare

2) Immediately actionable text and email Trade Alerts sent out at market sweet spots

3) Same-day answers to emailed questions about specific biotech companies

4) Special reports on the dominant trends and players in biotech and healthcare

5) Access to a biotech and healthcare ten-year database

Gaining an unfair advantage in the most important investment theme of your lifetime will be the best decision you ever made!

The Mad Hedge Biotech and Healthcare Letter is already listed in my store at $1,500 a year. If you subscribe this week only, you can obtain a founder’s price of only $997. Act fast. We’ll be taking down this one-time offer this weekend.

To take advantage of this unique opportunity please click here.

 

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail
https://www.madhedgefundtrader.com/wp-content/uploads/2019/10/DNA.png 466 302 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-10-04 07:04:212019-12-09 13:03:09Last Chance to buy the New Mad Hedge Biotech and Healthcare Letter at the Founders Price, or The Newsletter That May Save Your Life!

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Link to: October 2 Biweekly Strategy Webinar Q&A Link to: October 2 Biweekly Strategy Webinar Q&A October 2 Biweekly Strategy Webinar Q&A Link to: October 4, 2019 Link to: October 4, 2019 October 4, 2019
Scroll to top